This inventor holds 1 USPTO granted patent. Top assignees: Colorado State University Research Foundation, New York University. Active years: 2010.
Company Filing History:
1 out of 488 
1 out of 1,726 
Years Active: 2010
Title: Mark J Sartain: Innovator in Tuberculosis Diagnostics
Introduction
Mark J Sartain is a notable inventor based in Fort Collins, Colorado. He has made significant contributions to the field of medical diagnostics, particularly in the early detection of mycobacterial diseases such as tuberculosis. His innovative work has the potential to improve diagnostic accuracy and patient outcomes.
Latest Patents
Mark J Sartain holds a patent for "Biomarkers of tuberculosis that distinguish disease categories: use as serodiagnostic antigens." This patent discloses mycobacterial proteins from culture filtrate or cytosol that serve as useful B cell antigens for the early diagnosis of mycobacterial disease, especially in humans. The patent identifies four proteins that had not previously been recognized as B cell antigens, including LppZ, SodC, BfrB, and TrxC, each encoded by specific Mtb genes. The antigenic compositions include these proteins and/or peptide fragments, which can be combined with additional Mtb proteins known to be antigens. The patent also outlines methods and kits for utilizing these antigenic compositions for the early diagnosis of mycobacterial infections and diseases.
Career Highlights
Throughout his career, Mark J Sartain has worked with esteemed institutions, including the Colorado State University Research Foundation and New York University. His work has focused on advancing the understanding and diagnosis of mycobacterial diseases, contributing to the scientific community's efforts to combat these infections.
Collaborations
Mark has collaborated with notable colleagues such as John T Belisle and Suman Laal. These partnerships have enhanced his research and contributed to the development of innovative diagnostic methods.
Conclusion
Mark J Sartain's contributions to tuberculosis diagnostics exemplify the impact of innovative thinking in the medical field. His patented work on mycobacterial proteins represents a significant advancement in the early diagnosis of mycobacterial diseases.